Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurofeedback for Treatment-Resistant Depression
NCT04078438Terminated
- Sponsor
- Yeungnam University Medical Center
- Start
- Jun 2014
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Yeungnam University Medical Center. Primary endpoint: Hamilton Depression Rating Scale at 12 weeks. Started Jun 2014; status: terminated.
Beyond the preview
Go deeper on NCT04078438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078438.